Js. Bedingfield et al., NOVEL POTENT SELECTIVE PHENYLGLYCINE ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS, European journal of pharmacology, 309(1), 1996, pp. 71-78
The metabotropic glutamate (mGlu) receptor antagonist properties of no
vel phenylglycine analogues were investigated in adult rat cortical sl
ices (mGlu receptors negatively coupled to adenylyl cyclase), neonatal
rat cortical slices and in cultured rat cerebellar granule cells (mGl
u receptors coupled to phosphoinositide hydrolysis). (RS)-alpha-methyl
-4-phosphonophenylglycine (MPPG), (RS)-alpha-methyl-4-sulphonophenylgl
ycine (MSPG), (RS)-alpha-methyl-4-tetrazolylphenylglycine (MTPG), lpha
-methyl-3-carboxymethyl-4-hydroxyphenylglycine (M3CM4HPG) and ha-methy
l-4-hydroxy-3-phosphonomethylphenylglycine (M4H3PMPG) were demonstrate
d to have potent and selective effects against 10 mu M L-2-amino-4-pho
sphonobutyrate (L-AP4)- and 0.3 mu M (2S,1'S,2'S)-2-(2-carboxycyclopro
pyl)glycine (L-CCG-1)-mediated inhibition of forskolin-stimulated cAMP
accumulation in the adult rat cortex. In contrast, these compounds de
monstrated either weak or no antagonism at mGlu receptors coupled to p
hosphoinositide hydrolysis in either neonatal rat cortex or in culture
d cerebellar granule cells. These compounds thus appear to be useful d
iscriminatory pharmacological tools for mGlu receptors and form the ba
sis for the further development of novel antagonists.